NCT01649791 2016-06-30Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic LeukemiaRoswell Park Cancer InstitutePhase NA Terminated8 enrolled 9 charts
NCT00621452 2014-08-06Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin LymphomaFred Hutchinson Cancer CenterPhase 1 Completed12 enrolled